These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6483122)

  • 1. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.
    Conn PJ; Sanders-Bush E
    Neuropharmacology; 1984 Aug; 23(8):993-6. PubMed ID: 6483122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of serotonin stimulated phosphoinositide turnover.
    Conn PJ; Sanders-Bush E
    Life Sci; 1986 Feb; 38(7):663-9. PubMed ID: 3003490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
    Conn PJ; Sanders-Bush E; Hoffman BJ; Hartig PR
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4086-8. PubMed ID: 2940597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover.
    Roth BL; Nakaki T; Chuang DM; Costa E
    Neuropharmacology; 1984 Oct; 23(10):1223-5. PubMed ID: 6521858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.
    Sanders-Bush E; Breeding M; Knoth K; Tsutsumi M
    Psychopharmacology (Berl); 1989; 99(1):64-9. PubMed ID: 2550988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1985 Jul; 234(1):195-203. PubMed ID: 2989504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.
    Ashby CR; Minabe Y; Edwards E; Wang RY
    Brain Res; 1991 Jun; 550(2):181-91. PubMed ID: 1679370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site.
    Conn PJ; Sanders-Bush E
    J Neurosci; 1986 Dec; 6(12):3669-75. PubMed ID: 3025382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of various psychotropic agents on serotonin receptors and the transmembrane signal control].
    Mikuni M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):417-29. PubMed ID: 3610034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
    Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
    Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.
    Lampugnani MG; de Gaetano G
    Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of serotonin antagonists in a behavioral despair procedure in mice.
    Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
    Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
    Deliganis AV; Pierce PA; Peroutka SJ
    Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.
    Karasawa A; Kubo K; Shuto K; Nakamizo N
    Jpn J Pharmacol; 1985 Mar; 37(3):285-91. PubMed ID: 3158769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo.
    Müller-Schweinitzer E
    J Cardiovasc Pharmacol; 1986; 8(4):805-10. PubMed ID: 2427822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-mediated striatal dopamine release involves the dopamine uptake site and the serotonin receptor.
    Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 2000 Oct; 53(3):353-7. PubMed ID: 11113592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.
    Cadogan AK; Marsden CA; Tulloch I; Kendall DA
    Neuropharmacology; 1993 Mar; 32(3):249-56. PubMed ID: 8386340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
    Williams BC; Shaikh S; Edwards CR
    J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.